drugset / Trial / NCT07623057
A Study Testing the Safety and Effects of FB102 in Healthy Volunteers
RandomizedSequentialTriple-blindTreatment
Summary
The purpose of this Phase 1 trial is to evaluate the safety and effects of FB-102 in healthy volunteers following single and multiple doses.
Timeline
- Start
- 2026-06
- Primary completion
- 2027-02
- Completion
- 2027-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FB102 | Unknown | — | — |
Indications
No indication recorded.